IRIS Biotech
IRIS Biotech was established in 2001 as an offspring of the world wide operating enterprise CFM Oskar Tropitzsch whose origin goes back to the first chemical company founded in Germany in the 18th Century.
In the beginning of the 1980s, production was more and more outsourced to other locations around the world. As consequence, in 1985 the company was transformed into the currently-existing CFM Oskar Tropitzsch company, which kept administration in Germany and transferred production technology to different sites around the world.
Today's portfolio comprises a wide range from reagents for analytics, biotechnology to specialities and pharmaceutical intermediates. This engagement led in 1998 to the participation in the supply chain of raw materials for the largest peptide produced until today on solid support. In order to further strengthen CFM Oskar Tropitzsch's position in the Life Science market and to concentrate expertise and experience IRIS Biotech was founded as their sister concern.